<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a 65-year-old man diagnosed with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> arising from the intestine </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells had a mature B-cell immunophenotype and rearrangement of the c-myc gene </plain></SENT>
<SENT sid="2" pm="."><plain>The patient was treated with intensive multiagent chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>After four courses of chemotherapy, an <z:hpo ids='HP_0002595'>ileus</z:hpo> developed due to a residual abdominal disease </plain></SENT>
<SENT sid="4" pm="."><plain>We administered rituximab in combination with the same chemotherapy regimen </plain></SENT>
<SENT sid="5" pm="."><plain>A dramatic clinical improvement was observed and abnormal uptake by <z:chebi fb="0" ids="49134">18F-fluorodeoxyglucose</z:chebi> <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography disappeared </plain></SENT>
<SENT sid="6" pm="."><plain>The patient experienced complete remission for 1 year </plain></SENT>
<SENT sid="7" pm="."><plain>This encouraging result indicates that rituximab might be an important treatment choice in management of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>